The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. (Q45176358)
Jump to navigation
Jump to search
scientific article published in February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. |
scientific article published in February 2005 |
Statements
The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat (English)
Giovanni Tulipano
Elena Rossi
John E Taylor
Stefania Bonadonna
Vittorio Locatelli
Daniela Cocchi
Andrea Giustina
1 February 2005